ストックスクリーナーアプリを入手
26.63
2.60%
-0.71
前日終値:
$27.34
開ける：
$27.34
24時間の取引高:
514.97K
Relative Volume:
0.56
時価総額：
$1.33B
収益：
$290.38M
当期純損益:
$-21.03M
株価収益率:
-62.02
EPS:
-0.4294
ネットキャッシュフロー:
$-54.99M
1週間 パフォーマンス:
-7.19%
1か月 パフォーマンス:
-11.21%
6か月 パフォーマンス:
+20.00%
1年 パフォーマンス:
+60.31%
1日の値動き範囲:
$25.89
$27.41
1週間の範囲:
$25.89
$29.10
52週間の値動き範囲:
$15.59
$35.87
Staar Surgical Co Stock (STAA) Company Profile
Compare STAA vs ISRG, BDX, MDLN, ALC, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
26.63 | 1.36B | 290.38M | -21.03M | -54.99M | -0.4294 |
ISRG
Intuitive Surgical Inc
|
426.39 | 153.29B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
157.37 | 42.86B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
42.98 | 36.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.04 | 33.32B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
218.66 | 31.68B | 5.54B | 1.52B | 1.74B | 10.37 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-09 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2026-02-03 | 開始されました | Wedbush | Neutral |
| 2026-01-16 | 再開されました | Morgan Stanley | Underweight |
| 2025-04-21 | 開始されました | Wells Fargo | Equal Weight |
| 2025-02-12 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-02-12 | ダウングレード | Jefferies | Buy → Hold |
| 2025-02-12 | ダウングレード | Mizuho | Outperform → Neutral |
| 2025-02-12 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | アップグレード | BTIG Research | Neutral → Buy |
| 2024-03-11 | アップグレード | Stifel | Hold → Buy |
| 2023-12-05 | ダウングレード | Needham | Buy → Hold |
| 2023-12-04 | 開始されました | Morgan Stanley | Equal-Weight |
| 2023-09-15 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2023-08-03 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | 開始されました | Piper Sandler | Neutral |
| 2023-02-06 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-12-28 | 繰り返されました | BTIG Research | Buy |
| 2022-12-08 | 開始されました | Stifel | Hold |
| 2022-11-07 | アップグレード | Sidoti | Neutral → Buy |
| 2022-10-14 | 再開されました | Stephens | Overweight |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2022-04-08 | 開始されました | Needham | Buy |
| 2022-03-28 | アップグレード | The Benchmark Company | Hold → Buy |
| 2022-03-18 | アップグレード | BTIG Research | Neutral → Buy |
| 2021-07-09 | 開始されました | Oppenheimer | Perform |
| 2021-01-19 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2020-10-26 | ダウングレード | Sidoti | Buy → Neutral |
| 2020-08-31 | アップグレード | Sidoti | Neutral → Buy |
| 2020-08-06 | 繰り返されました | The Benchmark Company | Buy |
| 2020-07-06 | ダウングレード | Sidoti | Buy → Neutral |
| 2020-06-24 | ダウングレード | BTIG Research | Buy → Neutral |
| 2020-06-15 | 開始されました | Jefferies | Buy |
| 2019-12-04 | 開始されました | BTIG Research | Buy |
| 2018-09-24 | 繰り返されました | The Benchmark Company | Buy |
| 2018-08-06 | 再開されました | The Benchmark Company | Buy |
| 2017-11-20 | 繰り返されました | The Benchmark Company | Buy |
| 2017-08-14 | 繰り返されました | The Benchmark Company | Buy |
| 2017-03-03 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-18 | アップグレード | The Benchmark Company | Hold → Buy |
| 2013-09-10 | 再開されました | The Benchmark Company | Buy |
| 2013-02-28 | 繰り返されました | The Benchmark Company | Buy |
| 2012-11-01 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | 開始されました | Northland Securities | Outperform |
| 2011-10-25 | 繰り返されました | The Benchmark Company | Buy |
| 2010-10-12 | 開始されました | Morgan Joseph | Buy |
| 2010-05-11 | 開始されました | Benchmark | Buy |
すべてを表示
Staar Surgical Co (STAA) 最新ニュース
STAAR Surgical Co highlights its vision correction technology as investors weigh long-term growth - AD HOC NEWS
3 Reasons to Avoid STAA and 1 Stock to Buy Instead - Yahoo Finance
STAAR SURGICAL CO (STAA) Stock Chart - ChartMill
STAAR Surgical clears a key FDA milestone, shares in the medical device sector spotlight - AD HOC NEWS
STAAR Surgical (STAA) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Form 4 STAAR Surgical Company For: 23 June By Investing.com - Investing.com Australia
5 must-read analyst questions from STAAR Surgical’s Q1 earnings call - MSN
Director of STAAR Surgical (NASDAQ: STAA) receives grant of 11,145 stock options - Stock Titan
Form 4 STAAR Surgical Company For: 22 June By Investing.com - Investing.com Nigeria
STAAR Surgical (STAA) director awarded 11,145 stock options at $29.12 strike - Stock Titan
Director Neal Bradsher granted 11,145 STAAR Surgical (STAA) stock options - Stock Titan
STAAR Surgical (NASDAQ: STAA) director adds shares and options in equity grants - Stock Titan
STAAR Surgical (STAA) adds 3.9M plan shares, elects board and ratifies BDO - Stock Titan
[Form 4] STAAR SURGICAL CO Insider Trading Activity - Stock Titan
STAAR Surgical (STAA) director Jiang Wei exercises RSUs and receives new grant - Stock Titan
STAAR Surgical (STAA) director awarded RSUs and exercises prior units - Stock Titan
STAAR Surgical StockAnalyst views and long-term growth drivers - Ad-hoc-news.de
STAAR Surgical Co (STAA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
STAAR Surgical Co (STAA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
STAAR Surgical Co (STAA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
STAAR Surgical Co (STAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
STAAR Surgical Co (STAA) Valuation: PE, PB & Fair Value Analysis - TradingKey
STAAR Surgical Co (STAA) Institutional Confidence - TradingKey
STAAR Surgical Co (STAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
STAAR Surgical Co (STAA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
STAAR Surgical Co (STAA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Is STAAR Surgical Regaining Market Momentum? - Kalkine Media
STAAR Surgical (STAA) Stock Could Be 4.4% Undervalued Despite Its Rich P S Multiple - simplywall.st
Director Lilian Zhou of STAAR Surgical (STAA) receives 3,530-share stock award - Stock Titan
Medical Devices & SuppliesSpecialty Stocks Q1 Earnings: STAAR Surgical (NASDAQ:STAA) Firing on All Cylinders - Yahoo Finance
STAAR Surgical Raises Pay for Interim Co-CEO Andrews - The Globe and Mail
STAAR appoints Deborah Andrews as Interim Co-CEO and CFO with pay increase - TradingView
STAAR Surgical (STAA) boosts interim co-CEO and CFO Deborah Andrews’ salary and bonus - Stock Titan
CenterBook Partners LP Buys New Position in STAAR Surgical Company $STAA - MarketBeat
STAA News | STAAR SURGICAL CO (NASDAQ:STAA) - ChartMill
1 Russell 2000 Stock with Exciting Potential and 2 We Ignore - Yahoo Finance
How The STAAR Surgical (STAA) Story Is Shifting After Q1 And New Analyst Targets - Yahoo Finance
Midday Stock Roundup: TTM, Western Technology Up - Orange County Business Journal
STAAR Surgical Stock Hits Day Low of $29.03 Amid Price Pressure - MarketsMojo
Hedge Fund Broadwood Capital Added Over 1 Million Shares of STAAR Surgical to Its Position. Here's What That Means for Investors. - The Motley Fool
Staar Surgical Q1 Signals Potential Turnaround - Orange County Business Journal
STAAR Surgical Co stock (US8577001096): shares consolidate after Q1-driven jump on Nasdaq - AD HOC NEWS
STAAStaar Surgical Co Short Interest - Finviz
STAA Reiterated by Wedbush -- Price Target Maintained at $40 - GuruFocus
Staar Surgical Co (STAA) Stock Down 7.3% -- Now Undervalued? GF Score: 81/100 - GuruFocus
STAAR Surgical Co stock (US8577001096): shares softer after recent earnings jump and ongoing volatil - AD HOC NEWS
Staar Surgical Co (STAA) 財務データ
収益
当期純利益
現金流量
EPS
Staar Surgical Co (STAA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| SILVERMAN LOU | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
10,683 |
0 |
11,158 |
| Jiang Wei | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
10,683 |
0 |
77,127 |
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 14 '26 |
Option Exercise |
0.00 |
29,325 |
0 |
63,588 |
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 12 '26 |
Option Exercise |
0.00 |
8,175 |
0 |
34,263 |
| Michna Magda | Chief Development Officer |
Mar 14 '26 |
Option Exercise |
0.00 |
17,595 |
0 |
36,001 |
| Michna Magda | Chief Development Officer |
Mar 12 '26 |
Option Exercise |
0.00 |
6,178 |
0 |
20,622 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 13 '26 |
Buy |
18.61 |
316,017 |
5,882,656 |
16,123,842 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 12 '26 |
Buy |
18.12 |
299,432 |
5,424,330 |
15,807,825 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 11 '26 |
Buy |
17.52 |
54,764 |
959,558 |
15,508,393 |
| Jiang Wei | Director |
Jan 12 '26 |
Option Exercise |
0.00 |
20,967 |
0 |
66,444 |
2.39%
2.44%
大文字化:
|
ボリューム (24 時間):